Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21508Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Elisaf, M. S. | en |
| dc.contributor.author | Panteli, K. | en |
| dc.contributor.author | Theodorou, J. | en |
| dc.contributor.author | Siamopoulos, K. C. | en |
| dc.date.accessioned | 2015-11-24T19:15:24Z | - |
| dc.date.available | 2015-11-24T19:15:24Z | - |
| dc.identifier.issn | 0953-1424 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21508 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Alkalosis/complications | en |
| dc.subject | Creatinine/urine | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Hypocalcemia/complications | en |
| dc.subject | Hypokalemia/complications | en |
| dc.subject | Hypophosphatemia/complications | en |
| dc.subject | Magnesium/blood/*urine | en |
| dc.subject | Magnesium Deficiency/complications/*urine | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.title | Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/9513927 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1997 | - |
| heal.abstract | The aim of our study was the determination of fractional excretion of magnesium (FEMg++) in both normal subjects and hypomagnesemic patients. 142 subjects aged 26-72 years, recruited from our lipid clinic (control population) and 74 hypomagnesemic patients, aged 36-75 years, were studied. The mean FEMg++ in the control population was 1.8 per cent (range, 0.5-4 per cent). FEMg++ was not correlated with either serum magnesium or with serum creatinine. The mean FEMg++ in patients with hypomagnesemia of extrarenal origin was 1.4 per cent (range, 0.5-2.7 per cent), while the mean FEMg++ in hypomagnesemic patients in whom renal magnesium loss was the main etiologic factor for the pathogenesis of hypomagnesemia was 15 per cent (range, 4-48 per cent). In both groups of hypomagnesemic patients FEMg++ was positively correlated with the urinary magnesium to creatinine molar ratio, but was not correlated with serum magnesium or creatinine levels. FEMg++ could better distinguish the two groups of hypomagnesemic patients than the urinary magnesium to creatinine molar ratio. Hypomagnesemic patients exhibited a cluster of other acid-base and electrolyte abnormalities, mainly respiratory alkalosis, hypokalemia, hypophosphatemia, and hypocalcemia. In conclusion, in hypomagnesemic patients with normal renal function FEMg++ is a very useful tool for the diagnostic approach of hypomagnesemia. A value more than 4 per cent is indicative of inappropriate magnesium loss. | en |
| heal.journalName | Magnes Res | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
